Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
Quick Connect

White Paper

Palbociclib – how a novel process development approach provides IP advantages

This whitepaper outlines how Dr. Reddy's holistic development approach can help our API partners across geographies to provide patients early access to the generic alternative of Palbocicilb while gaining or maintaining competitive advantages.

Our team of process experts draw on their integrated understanding of IP, process development (API and formulation), and API manufacturing to ensure that by design the process is lean, free from potential genotoxic impurities and  scalable to manufacture for early market entries.

To continue on reading our latest whitepaer please fill the contact form below :

You can also explore our Palbocicilb API offering by clicking on the link below:

https://api.drreddys.com/product/palbociclib

Explore other Whitepapers:

Know More

Download Now

Please fill the Contact form below in order to view the white paper

Email us: api@drreddys.com | +91 40 49002222

Disclaimer

No information in this catalog - including any reference to any product or service - constitutes an offer for sale, or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. Products protected under valid patents in India are not available for commercial use but would be available for Section 107A purposes.

X

Have you booked your
CPHI Japan meeting slot yet?

Join us at booth: 5N-12

17th-19th April 2024

East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan

Schedule a meeting